117 related articles for article (PubMed ID: 33568330)
1. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.
Pacułt J; Rams-Baron M; Chmiel K; Jurkiewicz K; Antosik A; Szafraniec J; Kurek M; Jachowicz R; Paluch M
Eur J Pharm Sci; 2021 Apr; 159():105697. PubMed ID: 33568330
[TBL] [Abstract][Full Text] [Related]
2. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.
Pacult J; Rams-Baron M; Chmiel K; Jurkiewicz K; Antosik A; Szafraniec J; Kurek M; Jachowicz R; Paluch M
Eur J Pharm Sci; 2019 Aug; 136():104947. PubMed ID: 31170526
[TBL] [Abstract][Full Text] [Related]
3. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
5. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
[TBL] [Abstract][Full Text] [Related]
6. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
7. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
8. A New Method To Identify Physically Stable Concentration of Amorphous Solid Dispersions (I): Case of Flutamide + Kollidon VA64.
Chmiel K; Knapik-Kowalczuk J; Jurkiewicz K; Sawicki W; Jachowicz R; Paluch M
Mol Pharm; 2017 Oct; 14(10):3370-3380. PubMed ID: 28787567
[TBL] [Abstract][Full Text] [Related]
9. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
10. Molecular Disorder of Bicalutamide-Amorphous Solid Dispersions Obtained by Solvent Methods.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Gawlak K; Kurek M; Szlęk J; Jamróz W; Paluch M; Jachowicz R
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30340413
[TBL] [Abstract][Full Text] [Related]
11. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
12. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
14. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
16. Broadband dielectric spectroscopy as an experimental alternative to calorimetric determination of the solubility of drugs into polymer matrix: Case of flutamide and various polymeric matrixes.
Chmiel K; Knapik-Kowalczuk J; Jachowicz R; Paluch M
Eur J Pharm Biopharm; 2019 Mar; 136():231-239. PubMed ID: 30703545
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
18. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
19. Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement.
Ponnammal P; Kanaujia P; Yani Y; Ng WK; Tan RBH
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29547585
[TBL] [Abstract][Full Text] [Related]
20. Molecular Dynamics and Physical Stability of Ibuprofen in Binary Mixtures with an Acetylated Derivative of Maltose.
Grzybowska K; Grzybowski A; Knapik-Kowalczuk J; Chmiel K; Woyna-Orlewicz K; Szafraniec-Szczęsny J; Antosik-Rogóż A; Jachowicz R; Kowalska-Szojda K; Lodowski P; Paluch M
Mol Pharm; 2020 Aug; 17(8):3087-3105. PubMed ID: 32584584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
